slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 31,171-31,200
Pages 1,935
Rows per page 30
Slide function
31,171-31,200 of 58,039
40
The table highlights IRR, payback period, and cash flow metrics to demonstrate business viability.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
41
Includes specific financial targets for energy sold, revenue, and EBITDA.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
46
Includes a background image of a woman in a car, likely related to the company's branding.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
49
The table includes both half-year (1H) and full-year data points.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
49
The table includes both half-year (1H) and full-year data points.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
11
The slide uses a hub-and-spoke diagram to illustrate the network ecosystem.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
37
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
38
The slide shows two line charts side-by-side tracking margin improvements.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
39
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
40
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
41
The chart tracks trailing twelve months of revenue.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Satisfaction1 hit
42
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Satisfaction1 hit
47
The table provides quarterly and annual breakdowns for 2021 and partial 2022 data.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
48
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
49
The slide provides a detailed breakdown of adjustments including acquisition-related amortization and stock-based compensation expense.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
50
Data is unaudited and presented in millions.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
51
The slide contains two distinct financial tables: one for Free Cash Flow and one for Free Cash Flow as a percentage of revenue.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
52
The table reconciles GAAP weighted shares to Non-GAAP weighted shares by adjusting for the net effect of convertible notes and note hedges.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
53
The table provides a breakdown of Total Debt, Total Cash, and TTM Adjusted EBITDA to derive Net Leverage.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
54
The table reconciles GAAP operating income to non-GAAP Adjusted EBITDA by adding back depreciation, amortization, impairments, stock-based compensation, and transaction costs.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
21
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
25
Includes segment-level breakdown for AOS Manufacturing, Outdoor Online Marketplace, and Corporate.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
26
Includes a footnote regarding excise taxes.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
24
The chart displays a time-course study of VAS (Visual Analog Scale) scores for 'feeling high' across three cohorts.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
25
VAS = Visual Analog Scale. Data shows a significant reduction in subjective 'high' feeling with ANEB-001 compared to placebo.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
26
The data shows a significant reduction in the proportion of subjects feeling high when treated with ANEB-001 compared to placebo.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
27
The chart shows a reduction in body sway for both 50mg and 100mg doses of ANEB-001 compared to placebo.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
28
The chart displays mean values with 95% confidence intervals. Statistical significance is indicated by asterisks.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
34
Includes a smaller inset chart comparing current data to prior 50/100 mg dose data.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
35
Includes a smaller inset chart showing prior 50/100 mg data for comparison.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit